Maravai Lifesciences Holdings (MRVI) Cash from Operations (2020 - 2026)

Maravai Lifesciences Holdings' Cash from Operations history runs 7 years deep, the most recent figure standing at 8665000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations rose 192.28% year-over-year to 8665000.0 in Q1 2026; TTM through Mar 2026 was 39518000.0, a 704.07% decrease from a year earlier, with the FY2025 full-year figure at 57573000.0, down 871.24% from the prior year.
• Cash from Operations climbed to 8665000.0 in Q1 2026 per MRVI's latest filing, from 22768000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 164279000.0 in Q2 2022 and bottomed at 22768000.0 in Q4 2025.
• The 5-year median for Cash from Operations is 13136000.0 (2024), against an average of 36515176.47.
• Across the five-year window, Cash from Operations jumped 323.48% in 2022 and sank 287.91% in 2024, its largest moves.
• Year by year, Cash from Operations stood at 99335000.0 in 2022, then tumbled by 92.16% to 7790000.0 in 2023, then sank by 287.91% to 14638000.0 in 2024, then tumbled by 55.54% to 22768000.0 in 2025, then soared by 138.06% to 8665000.0 in 2026.
• Per Business Quant, the three latest MRVI Cash from Operations figures stand at 8665000.0 (Q1 2026), 22768000.0 (Q4 2025), and 15150000.0 (Q3 2025).